| Medical Condition | Atopic Dermatitis |
| Facility/Clinic | Accellacare – 8115 Market St Suite 211 |
| Age | 18 years and older |
| Gender | Male & Female |
| Description | A Phase 3, 52-week study evaluation of AMG 451 in combination with topical corticosteroid in adult subjects with moderate-to-severe atopic dermatitis (eczema). |
| Enrollment | Open |
| Patient Commitment Duration | 40 weeks |
| Number of visits in study | 10 visits |
| Patient Compensation | $100 per visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.